NCT07649486

Association Between Disease Severity and Clinical, Histopathological, and Eosinophilic Markers in Patients With Bullous Pemphigoid (BP-EPIC)

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-05-04Est. Completion: 2026-12-24

Enrollment target: 50 participants

Locations

S.B.Ü. İstanbul Eğitim ve Araştırma Hastanesi, Istanbul, FATİH, Turkey (Türkiye)

Other microbiome trials you might be interested in

Topical Steroids Alone or Associated With Methotrexate in Bullous PemphigoidPhase 3Completed

Bullous Pemphigoid

This controlled multi-center randomized clinical trial, with direct individual benefit, will compare efficacy and safety…

Montpellier, FranceCompleted May 26, 2015

View Trial →

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)Phase 1Recruiting

Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)Dermatomyositis (DM)Immune-mediated Necrotizing Myopathy (IMNM)Immune Thrombocytopenia (ITP)

This Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.